377 related articles for article (PubMed ID: 16517170)
1. Synthesis and antiproliferative activity of N-substituted 2-amino-5-(2,4-dihydroxyphenyl)-1,3,4-thiadiazoles.
Matysiak J; Opolski A
Bioorg Med Chem; 2006 Jul; 14(13):4483-9. PubMed ID: 16517170
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and antiproliferative activity of some 5-substituted 2-(2,4-dihydroxyphenyl)-1,3,4-thiadiazoles.
Matysiak J; Nasulewicz A; Pełczyńska M; Switalska M; Jaroszewicz I; Opolski A
Eur J Med Chem; 2006 Apr; 41(4):475-82. PubMed ID: 16517026
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of antiproliferative effect in vitro of some 2-amino-5-(2,4-dihydroxyphenyl)-1,3,4-thiadiazole derivatives.
Matysiak J
Chem Pharm Bull (Tokyo); 2006 Jul; 54(7):988-91. PubMed ID: 16819217
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of electronic, lipophilic and membrane affinity effects on antiproliferative activity of 5-substituted-2-(2,4-dihydroxyphenyl)-1,3,4-thiadiazoles against various human cancer cells.
Matysiak J
Eur J Med Chem; 2007 Jul; 42(7):940-7. PubMed ID: 17320247
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of new chiral 2,5-disubstituted 1,3,4-thiadiazoles possessing gamma-butenolide moiety and preliminary evaluation of in vitro anticancer activity.
Wei MX; Feng L; Li XQ; Zhou XZ; Shao ZH
Eur J Med Chem; 2009 Aug; 44(8):3340-4. PubMed ID: 19371980
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and anticancer activity of new 2-aryl-4h-3,1-benzothiazines.
Niewiadomy A; Matysiak J; Karpińska MM
Arch Pharm (Weinheim); 2011 Apr; 344(4):224-30. PubMed ID: 21469171
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of novel 4-(1H-benzimidazol-2-yl)benzene-1,3-diols and their cytotoxic activity against human cancer cell lines.
Karpińka MM; Matysiak J; Niewiadomy A
Arch Pharm Res; 2011 Oct; 34(10):1639-47. PubMed ID: 22076764
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, determination of the lipophilicity, anticancer and antimicrobial properties of some fused 1,2,4-triazole derivatives.
Sztanke K; Tuzimski T; Rzymowska J; Pasternak K; Kandefer-Szerszeń M
Eur J Med Chem; 2008 Feb; 43(2):404-19. PubMed ID: 17531354
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological evaluation of 3,6-disubstituted [1,2,4]triazolo[3,4-b][1,3,4]thiadiazole derivatives as a novel class of potential anti-tumor agents.
Ibrahim DA
Eur J Med Chem; 2009 Jul; 44(7):2776-81. PubMed ID: 19203813
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and in-vitro anticancer activity of 3,5-bis(indolyl)-1,2,4-thiadiazoles.
Kumar D; Kumar NM; Chang KH; Gupta R; Shah K
Bioorg Med Chem Lett; 2011 Oct; 21(19):5897-900. PubMed ID: 21873049
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and anticancer activity of 5-(3-indolyl)-1,3,4-thiadiazoles.
Kumar D; Maruthi Kumar N; Chang KH; Shah K
Eur J Med Chem; 2010 Oct; 45(10):4664-8. PubMed ID: 20692741
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and antiproliferative studies of 5-aryl-2-(3-thienylamino)-1,3,4-thiadiazoles.
Revelant G; Gadais C; Mathieu V; Kirsch G; Hesse S
Bioorg Med Chem Lett; 2014 Jun; 24(12):2724-7. PubMed ID: 24815511
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and anticancer evaluation of novel 2-cyclopropylimidazo[2,1-b][1,3,4]-thiadiazole derivatives.
Noolvi MN; Patel HM; Singh N; Gadad AK; Cameotra SS; Badiger A
Eur J Med Chem; 2011 Sep; 46(9):4411-8. PubMed ID: 21820217
[TBL] [Abstract][Full Text] [Related]
14. NMR QSAR model for the analysis of 4-(5-arylamino-1,3,4-thiadiazol-2-yl)benzene-1,3-diols.
Matysiak J; Niewiadomy A; Paw B; Dybała I
Arch Pharm (Weinheim); 2011 May; 344(5):340-4. PubMed ID: 21290429
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, structure elucidation and identification of antitumoural properties of novel fused 1,2,4-triazine aryl derivatives.
Sztanke K; Pasternak K; Rzymowska J; Sztanke M; Kandefer-Szerszeń M
Eur J Med Chem; 2008 May; 43(5):1085-94. PubMed ID: 17868955
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, structure, and bioactivity of N'-substituted benzylidene-3,4,5-trimethoxybenzohydrazide and 3-acetyl-2-substituted phenyl-5-(3,4,5-trimethoxyphenyl)-2,3-dihydro-1,3,4-oxadiazole derivatives.
Jin L; Chen J; Song B; Chen Z; Yang S; Li Q; Hu D; Xu R
Bioorg Med Chem Lett; 2006 Oct; 16(19):5036-40. PubMed ID: 16876405
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and antitumor-evaluation of 1,3-selenazole-containing 1,3,4-thiadiazole derivatives.
Zhao HC; Shi YP; Liu YM; Li CW; Xuan LN; Wang P; Zhang K; Chen BQ
Bioorg Med Chem Lett; 2013 Dec; 23(24):6577-9. PubMed ID: 24239016
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and anticancer activity of new 1-substituted-6H-pyrido[4,3-b]carbazole derivatives.
Tylińska B; Jasztold-Howorko R; Mastalarz H; Szczaurska-Nowak K; Wietrzyk J
Arch Pharm (Weinheim); 2008 Jun; 341(6):351-6. PubMed ID: 18404778
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, crystal structure and anticancer activity of novel derivatives of ethyl 1-(4-oxo-8-aryl-4,6,7,8-tetrahydroimidazo[2,1-c][1,2,4]triazin-3-yl)formate.
Sztanke K; Rzymowska J; Niemczyk M; Dybała I; Kozioł AE
Eur J Med Chem; 2006 Apr; 41(4):539-47. PubMed ID: 16545495
[TBL] [Abstract][Full Text] [Related]
20. Novel derivatives of methyl and ethyl 2-(4-oxo-8-aryl-2H-3,4,6,7-tetrahydroimidazo[2,1-c][1,2,4]triazin-3-yl)acetates from biologically active 1-aryl-2-hydrazinoimidazolines: synthesis, crystal structure and antiproliferative activity.
Sztanke K; Rzymowska J; Niemczyk M; Dybała I; Kozioł AE
Eur J Med Chem; 2006 Dec; 41(12):1373-84. PubMed ID: 16996655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]